ATRACURIUM BESYLATE INJECTION
ATRACURIUM BESYLATE INJECTION
Discontinued
DIN Number
02236319
Drug Class
Human
Market Date
Jul 13, 1998
Company
HC
hospira healthcare ulc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02236319
AIG Number0116898001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
M03AC04 ATRACURIUM
Product Specifications
Dosage FormSolution
Route of AdministrationIntravenous
AHFS Classification12:20.20
Health Canada Classification
ACTIVE INGREDIENTS (1)
ATRACURIUM BESYLATEActive
Strength: 10 MG / ML
Monograph: ATRACURIUM BESYLATE